Day One Biopharmaceuticals is dedicated to discovering and developing innovative therapies that address the unique needs of individuals of all ages living with cancer. Leveraging advances in cancer research, the company aims to provide effective medications for both children and adults, focusing on the biology of childhood cancer. Through collaboration with pediatric oncology experts, Day One strives to translate promising discoveries into tangible benefits for patients as swiftly as possible.